On its release in 1994, Pitchfork said, “It’s colossal, it teems with innovation ... and works by Miles Davis, Art Blakey, Max Roach and more (7:30 p.m. Jan. 25). At Symphony Center ...

Embrace the bug life with 5 quirky destinations where insects steal the spotlight, from roach-filled caves in Borneo to ...

Colossal Biosciences – the company behind an ambitious, Jurassic Park-style effort to revive extinct bird and mammal species such as the thylacine, dodo and woolly mammoth – said it had raised ...

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation ...

Anchoring the exhibition is an expansive and immersive work of 100,000-plus dried flowers by Rebecca Louise Law. Smaller ...

Dr. Beth Shapiro, Ph.D. (Lead Paleogeneticist and Colossal Scientific Advisory Board Member) and Ben Lamm (Colossal Co-Founder and CEO). Image courtesy of Colossal Biosciences.(Colossal ...

Learn More Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth. Dallas- and Boston-based Colossal is making strides in the ...

The tank had to be made by specialists usually involved in art installations. If the museum ever finds itself lucky enough to take delivery of a complete colossal squid, they might have to build ...

Dallas-based Colossal has put itself into a unique class of businesses: a decacorn. There are only 75 such privately-held companies—those holding a valuation of $10 billion or more—on the ...

In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding.